Fig. 7 | Scientific Reports

Fig. 7

From: Machine learning identifies SRD5A3 as a propionate-related prognostic biomarker in triple-negative breast cancer

Fig. 7

Immune checkpoint-related genes and drug-sensitivity prediction in TNBC patients. (A–H) The different expression levels of immune checkpoint genes and the different TIDE scores between high-risk and low-risk groups in the training (A, B, C, and D) and validation (E, F, G, and H) cohorts, p < 0.05 was regarded statistically significant. (I and J) The difference in the estimated IC50 of the six representative chemotherapeutic drugs between the two risk groups (p < 0.001 was represented as *** and p < 0.05 was represented as *).

Back to article page